If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Azad is an early-career medical oncologist and translational researcher with a special interest in genitourinary malignancies.
After completing his medical oncology training and a PhD in cell biology in Melbourne, Dr Azad moved to the British Columbia (BC) Cancer Agency and Vancouver Prostate Centre, Canada for a 2-year fellowship under the supervision of Professor Kim Chi, an internationally renowned prostate cancer researcher.
At BC Cancer Agency, Dr Azad played a major role in the development of five investigator-initiated clinical trials, was actively involved in outcomes research, and led pioneering studies centred on genomic profiling of circulating cell-free DNA in advanced prostate cancer patients developing resistance to next-generation hormonal agents. The significance of Dr Azad's work with cell-free DNA was recognized by four highly prestigious Merit Awards from the American Society of Clinical Oncology and first author publications in Clinical Cancer Research and JAMA Oncology.
Dr Azad has a strong academic record including 64 publications, a patent, 11 oral presentations at national and international meetings, Poster Highlights Sessions at the 2014 and 2015 ASCO Annual Meeting, 22 competitive prizes and awards and over $4.5M in competitive funding.
In November 2015, Dr Azad commenced appointments at Monash University and Monash Health, where he is leading a clinical and translational prostate cancer research program. His ongoing research centres on circulating biomarker analysis in advanced prostate cancer patients (supported by an NHMRC Project Grant) and the predictive utility of non-coding RNA for BET inhibition in prostate cancer (supported by a Victorian Cancer Agency Translational Research Project Grant). He is also actively involved in clinical trials and notably is the lead Australian investigator for two clinical trials in advanced prostate cancer patients. 

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2023

Research Output 2006 2019

9 Citations (Scopus)

Cell-free DNA in cancer: current insights

Fettke, H., Kwan, E. M. & Azad, A. A., 15 Feb 2019, In : Cellular Oncology. 42, 1, p. 13-28 16 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)

Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team

Murphy, D. G., Hofman, M. S., Azad, A., Violet, J., Hicks, R. J. & Lawrentschuk, N., Jan 2019, In : BJU International. 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Novel agents for metastatic hormone-sensitive prostate cancer – a practice guide for urologists

Thangasamy, I. A., Kwan, E. M., Teh, J., Sathianathen, N., Alghazo, O., Siva, S., Azad, A. & Murphy, D. G., 29 Oct 2019, (Accepted/In press) In : BJU International. 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer

Kwan, E. M., Fettke, H., Docanto, M. M., To, S. Q., Bukczynska, P., Mant, A., Pook, D., Ng, N., Graham, L. J. K., Mangiola, S., Segelov, E., Mahon, K., Davis, I. D., Parente, P., Pezaro, C., Todenhöfer, T., Horvath, L. G. & Azad, A. A., 15 May 2019, (Accepted/In press) In : European Urology Focus. 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics

Murphy, D. G., Azad, A. A., Sandhu, S., Violet, J. & Hofman, M. S., Jun 2019, In : European Urology. 75, 6, p. 927-928 2 p.

Research output: Contribution to journalEditorialOtherpeer-review